Peter F. Thall
Genetics · 2000–2020
A researcher in the Science corpus: 5 papers; trusts 2 researchers and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Genetics — 10 citations into it
- Statistics and Probability — 10 citations into it; #6,111 of 12,932 by trust here, #3,893 by citations
Whom Peter F. Thall trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Peter F. Thall overall
- Susan A. Murphy
- D. Almirall
- Rui Song
- Abiral Baniya
- Erica E. Moodie
- Susan M. Shortreed
- Donglin Zeng
- R. Dawson
- Michael R. Kosorok
- W. Wang
Papers from Peter F. Thall's perspective
Ordered by how strongly the researchers Peter F. Thall trusts endorse each paper. Same corpus, a different order for every researcher.
- A design for testing clinical strategies: biased adaptive within‐subject randomization
- INFERENCE AND MISSING DATA
- Bayesian Inference for Causal Effects: The Role of Randomization
- Marginal Mean Models for Dynamic Regimes
- Optimal Structural Nested Models for Optimal Sequential Decisions
- Dynamic treatment regimes: practical design considerations
- Optimal dynamic treatment regimes
- An experimental design for the development of adaptive treatment strategies
- Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. (Journal of Clinical Oncology)
- Statistical Analysis With Missing Data
Their papers
- Covariate‐adjusted adaptive randomization in a sarcoma trial with multi‐stage treatments (2005) — 74 citations
- Evaluating multiple treatment courses in clinical trials. (2000) — 151 citations
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors (2020) — 1,747 citations
- Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. (2007) — 643 citations
- Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. (2001) — 638 citations